The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
https://www.lsegissuerservices.com/spark/Synairgen/events/28f37f03-c7dd-4071-b047-66b191931742
definitely a suitable name. Firstly, the likelihood of either company releasing their data on time is low and I expect it to be in Q1 2022. Secondly, even if the data is released, yes I would expect a drop in the sp here for a short period, but all will be forgotten when our results are read out. There is more than enough room for multiple therapies in this area.
I read this as a very good thing. We have plenty of money at the moment, the only reason to raise would be to commercialize the product in house i.e. not sell the company. And that raise would be at an SP a lot higher than it is today because it would be after PIII readout
Unlike you, these swings don't bother me. You are psychologically invested in this share, to the extent you constantly require your bias to be confirmed on here, either by agreeing with people with the same view as you, or by arguing with people who don't. Maybe you need to take some time off the screen and relax. Its not that deep.
All you have done for over a year is post on this board daily and argue with people to serve your own confirmation bias. You literally have nothing better to do hence I ask if you have a job, because you certainly have a lot of time.